Next Article in Journal
Microbiota in Mild Inflammatory Bowel Disease (IBD) Can Be Modulated by Beta-Glucans and Mannanoligosaccharides: A Randomized, Double-Blinded Study in Dogs
Previous Article in Journal
Transcriptomic Signatures of the Foetal Liver and Late Prenatal Development in Vitrified Rabbit Embryos
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Isolation of the Initial Bovine Alphaherpesvirus 1 Isolate from Yanbian, China

1
Department of Veterinary Medicine, College of Agricultural, Yanbian University, Yanji 133002, China
2
Department of Animal Disease Prevention and Control Centre, Longjing 133400, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Submission received: 16 May 2024 / Revised: 2 July 2024 / Accepted: 29 July 2024 / Published: 1 August 2024

Abstract

:

Simple Summary

Bovine infectious rhinotracheitis (IBR) is a severe, febrile, and highly contagious disease caused by bovine alphaherpesvirus 1 (BoAHV1), resulting in substantial economic losses in the cattle industry worldwide. Despite its significant impact, there is a dearth of comprehensive research on the genetic characteristics and infection dynamics of BoAHV1. This study represents a pivotal milestone as it successfully isolated a BoAHV1 strain for the first time from a cattle farm in Yanji city, revealing the genetic evolutionary characteristics of BoAHV1 and the expression dynamics of its associated glycoprotein genes within host cells. Notably, the exceptional disease resistance displayed by Yanbian yellow cattle has rendered previous reports on their susceptibility to BoAHV1 infection nonexistent. These findings underscore the importance of global collaboration in understanding and combating BoAHV1, offering crucial insights into its infection dynamics during host cell invasion.

Abstract

Bovine infectious rhinotracheitis (IBR), caused by bovine alphaherpesvirus 1 (BoAHV1), poses significant challenges to the global cattle industry due to its high contagiousness and economic impact. In our study, we successfully isolated a BoAHV1 strain from suspected infected bovine nasal mucus samples in Yanji city, revealing genetic similarities with strains from Sichuan, Egypt, and the USA, while strains from Xinjiang, Beijing, Hebei, and Inner Mongolia showed more distant associations, indicating potential cross-border transmission. Additionally, our investigation of BoAHV1 infection dynamics within host cells revealed early upregulation of gB, which is critical for sustained infection, while the expression of gC and gD showed variations compared to previous studies. These findings enhance our understanding of BoAHV1 diversity and infection kinetics, underscoring the importance of international collaboration for effective surveillance and control strategies. Furthermore, they lay the groundwork for the development of targeted therapeutics and vaccines to mitigate the impact of IBR on the cattle industry.

1. Introduction

Bovine infectious rhinotracheitis (IBR), also known as red nose disease, is an acute, febrile, and contagious illness caused by bovine alphaherpesvirus 1 (BoAHV1) [1,2]. Clinically, it presents with inflammation of the respiratory tract and tracheal mucosa, dyspnea, and nasal discharge [3]. Additionally, it results in genital tract infections, conjunctivitis, meningoencephalitis, abortion, mastitis, and other ailments [4]. This disease is classified as a notifiable disease by the WOAH and a Class II animal infectious disease in China. It is influenced by viral virulence, host immune responses, host age, environmental conditions, and concurrent bacterial infections [5]. Moreover, IBR is a primary risk factor for bovine respiratory disease (BRD) [6], which is the most economically impactful disease in the cattle industry [7,8]. Concurrent infection with BoAHV1 and Mannheimia hemolytica (MH) is often linked to the development of BRD.
BoAHV1 is a member of the order Herpesvirales, family Orthoherpesviridae, subfamily Alphaherpesvirinae, genus Varicellovirus, and species Varicellovirus bovinealpha1 [9]. First identified in Los Angeles, USA, in the early 1950s [10,11], the virus was initially isolated by Madin et al. [12]. Subsequent studies recovered the virus from various tissues, including the conjunctiva, brain, vulva, and fetus of infected cattle [13]. In 1980, the first BoAHV1 strain was isolated in China from cattle imported from New Zealand [14]. Serological studies conducted across national cattle ranches revealed the presence of BoAHV1 in dairy cows, buffaloes, yellow cattle, and yaks [15,16]. BoAHV1 strains are classified into three subtypes, BoAHV1.1, BoAHV1.2a, and BoAHV1.2b, based on antigenic and genomic analyses [17]. BoAHV1.1, associated with the ‘classical’ form of IBR, primarily induces respiratory symptoms and is typically isolated from the respiratory tract and aborted fetuses [18]. Conversely, BoAHV1.2 predominantly infects the reproductive tract, leading to various reproductive disorders. As another significant species of bovine herpesvirus, BoAHV5 primarily induces diseases associated with the nervous system [19].
At the molecular level, BoAHV1 is a triple-component, double-stranded DNA (dsDNA) virus with a core, capsid, and envelope that measures approximately 150 to 200 nm in diameter [20]. The capsid takes the form of a stellate icosahedron with 162 radially arranged capsomeres enclosed within a lipid-containing membrane. The nucleocapsid, consisting of a core and a capsid, forms through the coiling of double-stranded DNA around proteins [21]. The BoAHV1 genome includes a long unique region (UL) of approximately 106 kb, a short unique region (US) of approximately 10 kb, and two identical inverted repeats (TRS and IRS), each approximately 11 kb [22]. It contains 73 open reading frames (ORFs) that encode 33 structural proteins [23,24]. Previous studies have highlighted the essential role of several glycoproteins, including gB, gC, gD, gE, gH, gK, and gL, derived from BoAHV1 in facilitating virus–cell interactions, with gB being the most conserved [25]. BoAHV1 can be transferred directly from infected cells to nearby uninfected cells by gB, which can cause the virus to enter target cells [26,27]. Notably, these glycoproteins adhere to receptors on the surface of host cells, mediating fusion between the virus and the cellular membrane, thereby facilitating viral entry into the intracellular environment. These pivotal processes are indispensable prerequisites for the effective invasion of host cells by the virus, constituting fundamental events in viral infection [28].
In this study, a BoAHV1 virus strain was isolated for the first time from nasal fluid samples obtained from suspected infected cattle at a cattle farm located in Yanji city. Subsequent analyses were conducted to characterize the genetic features and infection dynamics. Yanji city, located in the Yanbian Korean Autonomous Prefecture of China and bordering both North Korea and Russia, serves as a crucial hub for exchanges due to its strategic location. Yanbian yellow cattle, which are highly prized for their genetic traits resulting from extensive natural and artificial selection, are valuable assets in China’s husbandry [29]. Prior to this study, BoAHV1 had not been detected in Yanbian yellow cattle. Despite the exceptional disease resistance of Yanbian yellow cattle, the widespread dissemination of the BoAHV1 virus has significantly compromised this attribute. Therefore, a comprehensive understanding of the genetic variability and replication dynamics of BoAHV1 within host cells is crucial for developing effective control and prevention strategies.

2. Materials and Methods

2.1. Cell Line and Sample Collection

The MDBK cell line (Thermo Fisher Scientific, Waltham, MA, USA) was stored in liquid nitrogen in our laboratory. The cells were cultured in a cell culture mixture comprising 80% DMEM (Thermo Fisher Scientific, Waltham, MA, USA), 20% FBS (Tianhang, Zhejiang, China), and 1% penicillin-streptomycin. Clinical specimens were obtained from cattle suspected of having BoAHV1 infection at a farm located in Yanji city, China. The swab collection was authorized by management personnel. Mucosal samples from the nose cavity of 50 potentially infected cattle were collected using swabs. The sampling procedure was carried out with minimal disruption to the animals while the sampled cattle continued to be reared at the cattle farm. Subsequently, the collected samples underwent three freeze-thaw cycles, followed by dilution in a tenfold volume of phosphate-buffered saline (PBS) solution and homogenization using a tissue grinder. Finally, the samples were stored at −80 °C in our laboratory.

2.2. Cloning and Sequence Analysis of the gB Gene

The DNA extracted from the samples was obtained using a viral genomic DNA extraction kit (COWIB, Nanjing, China). Primer design for amplification of the partial gB gene sequence of the BoAHV1 strain (accession number: MG407792), obtained from GenBank, was conducted using Oligo6.0 software (Molecular Biology Insights, Amsterdam, USA). Primers for BoAHV1-gB-F/R were synthesized accordingly (Table 1). The PCR amplification process involved initial denaturation at 95 °C for 5 min, followed by 30 cycles of denaturation at 95 °C for 30 s, annealing at 59.2 °C for 30 s, and extension at 72 °C for 30 s, with a final extension step at 72 °C for 10 min.
A gel recovery kit (Omega Bio-tek, Norcross, GA, USA) was used to extract the target genes following the manufacturer’s instructions. Subsequently, the purified gene fragment was ligated into the pMD-19T vector (Takara, Kyoto, Japan) and transformed into competent Trans5α cells (TransGen Biotech Co., Ltd., Beijing, China). Monoclonal colonies of Escherichia coli were selected and subjected to PCR identification using the aforementioned primers and reaction conditions. Positive colonies were subsequently expanded, cultured, and sent for Sanger sequencing analysis (Kumei Biotechnology Co., Ltd., Changchun, China).

2.3. Virus Isolation

The homogenized samples were then centrifuged at 4000 rpm for 30 min at 4 °C. After centrifugation, the supernatant was filtered through a 0.22 μm bacterial filter for virus isolation. The filtrate was inoculated into a culture flask containing 90% confluent MDBK cells at a 5% volume, and the flask was placed in a 37 °C, 5% CO2 incubator. MDBK cells without virus inoculation were used as the mock infection control group. The supernatant containing the virus was collected and used to inoculate MDBK cell cultures. This process was repeated for five passages to ensure viral amplification. At each passage, the virus-infected cell cultures were subjected to three freeze-thaw cycles at −80 °C to lyse the cells and release the virus. After lysis, the supernatant was collected by centrifugation, filtered to remove cell debris, and then transferred to fresh cell cultures, allowing the virus to replicate until cytopathic effects (CPE) became evident. PCR was conducted on the viral suspension collected at each passage to monitor viral presence and amplification. After five passages, the virus solution was harvested and stored at −80 °C for subsequent experiments.

2.4. Virus Titration (TCID50)

The 5th passage of the BoAHV1-YBYJ virus solution was diluted across a gradient ranging from 10−1 to 10−9 and subsequently inoculated into 96-well cell plates, with eight replicates for each dilution. The cells were then incubated at 37 °C with 5% CO2 for 120 h. Following the observation of cytopathic effects (CPEs), the viral titer was determined using the Reed–Muench method.

2.5. Virus Growth Curve

MDBK cells were seeded into individual wells of a 48-well cell culture plate at a density of 6 × 104 cells/well. The BoAHV1-YBYJ virus was diluted to an MOI of 5, which corresponds to 3 × 105 virus particles per well, and subsequently used to infect the cells in a volume of 1 mL. Supernatants were collected at designated time points post-infection (0, 12, 24, 36, 48, 60, 72, 96, and 120 h), followed by TCID50 determination. A virus growth curve was constructed, plotting infection time on the x-axis and the logarithm of TCID50 values on the y-axis.

2.6. Indirect Immunofluorescence Assay (IFA)

MDBK cells were seeded into a 6-well plate and cultured until they reached 80% confluence. Each well was then inoculated with the 5th passage of the BoAHV1-YBYJ virus solution at an MOI of 1. After 40 h of inoculation, the MDBK cells were fixed with 4% paraformaldehyde at 37 °C for 30 min, permeabilized with 0.1% Triton X-100 at room temperature for 20 min, and then blocked with 5% BSA at 37 °C for 1 h. The cells were subsequently incubated overnight at 4 °C with 1:400 rabbit anti-BoAHV1 antibody (stored by our laboratory), followed by incubation in the dark at 37 °C for 1 h with 1:200 FITC-labeled goat anti-rabbit IgG (Affinity, Suzhou, China) as the fluorescent secondary antibody. Between each step, the cells were washed three times with PBS. Finally, an inverted fluorescence microscope (Olympus, Tokyo, Japan) was used for cell observation (10× ocular, 10× objective).

2.7. Transmission Electron Microscopy (TEM)

The 5th passage of the BoAHV1-YBYJ virus solution (2 mL) was concentrated using a 100 kD hollow fiber column (Rigorous, Shenzhen, China), followed by infiltration of copper mesh (GE Healthcare, Marlborough, MA, USA), fixation with glutaraldehyde, and staining with 2% phosphotungstic acid. The morphology of the virus particles was subsequently identified using transmission electron microscopy (Hitachi, Tokyo, Japan), and high-resolution images were captured with a digital camera (Olympus, Tokyo, Japan). Specifically, a Hitachi HT7700 transmission electron microscope with an accelerating voltage of 180 kV and a magnification of 30,000× was used. The electron beam current was set to 10 µA, with an exposure time of 1 s. The microscope’s resolution is 0.2 nm.

2.8. Analysis of the Genetic Evolution of Amino Acids

The sequencing results were sorted to identify the gB gene sequence and compared with the sequences of reference strains in the GenBank database (Table 2). The amino acid sequence of the gB gene was obtained by sequencing samples clinically confirmed as BoAHV1-positive. A genetic evolutionary tree was constructed for analysis based on published sequences in GenBank. Phylogenetic trees were generated utilizing MEGA X (Mega Limited, Auckland, New Zealand), with sequence alignment performed using the ClustalW algorithm, which employs the neighbor-joining method, and analyses conducted with 1000 bootstrap replicates.

2.9. BoAHV1-YBYJ Glycoprotein Gene Expression in MDBK Cells

A model of infection was established using the 5th passage of the BoAHV1-YBYJ virus solution in MDBK host cells, with the uninfected group serving as the control. Negative control groups were included to ensure the success of virus infection and to rule out experimental errors and chance results. MDBK cells were seeded in 6 well plates, and each well was inoculated with the 5th passage of the BoAHV1-YBYJ virus solution at a titer of 105.80 TCID50/0.1 mL with an MOI of 1. After 30 min of virus adsorption, the original virus solution was retained, and a cell maintenance medium was added to continue cultivation. Samples were collected from fifth-generation BoAHV1-infected MDBK cells at various time points (0.5, 1, 2, 4, 6, 8, 12, 24, 36, 48, and 60 h), and total RNA was extracted. RNA extraction was performed using a viral genomic RNA extraction kit (COWIB, Nanjing, China), with quality control measures in place to ensure the suitability of the collected RNA for subsequent experiments. The extracted RNA was then reverse-transcribed into cDNA using a reverse transcription kit (TaKaRa, Dalian, China) and stored at −80 °C. Subsequently, fluorescent quantitative PCR was performed to assess the mRNA levels of relevant glycoprotein genes at each time point. The primers used for the amplification of the gB, gC, gD, gE, gH, gK, and gL gene sequences of the BoAHV1 strain (accession number: MG407792) were designed using Oligo6.0 software (Molecular Biology Insights, Amsterdam, NY, USA). GAPDH was chosen as the housekeeping gene for this study. Fluorescent quantitative PCR primers for BoAHV1 were synthesized accordingly (Table 1). Quality control measures, including the assessment of reverse transcription efficiency and PCR specificity, were implemented to ensure the validity of the transcription and PCR results. The relative expression levels of target genes were determined using the 2−ΔΔCt method, allowing for the comparison of gene expression changes across experimental conditions. The experimental results were analyzed using ImageJ software (NIH, Bethesda, MD, USA). One-way ANOVA was performed with GraphPad Prism software 7.00 (GraphPad Software Inc., San Diego, CA, USA). The data were subjected to normality and log-normality tests, followed by multiple comparison methods for significance testing. In our analysis, **** p < 0.0001, *** p < 0.001 and ** p < 0.01 indicate highly significant differences, while * p < 0.05 indicates significant differences. Each experiment was conducted with three biological replicates (n = 3) to ensure experimental reproducibility and reliability.

3. Results

3.1. PCR Analysis of Test Samples

Fifty samples were tested using BoAHV1-specific primers targeting the gB gene, revealing the presence of a specific 567 bp DNA band in seven samples, which is indicative of BoAHV1 positivity (Figure 1). In this study, the initial agarose gel data from triplicate biological replicates have been uploaded as Supplementary Material (Figure S1).

3.2. Virus Isolation

Among the fifty tested samples, one of the seven BoAHV1-YBYJ positive samples identified by PCR was selected for virus isolation. In cells infected with the 5th passage inoculum, the cytopathic effect (CPE) became evident 40 h post-infection. Microscopic examination revealed cell rounding, netting, and grape-like string appearances (Figure 2a). In contrast, uninoculated cells cultured under the same conditions did not exhibit any CPEs (Figure 2b). To quantify the viral titer, the TCID50 of the isolated strain was determined to be 105.80 per 0.1 mL (Table S1). Furthermore, viral growth kinetics indicated a significant exponential increase in viral titers within the initial phase of infection, reaching peak levels at 24 h. Subsequently, viral titers gradually declined, stabilizing thereafter by 72 h post-infection (Figure 2c).

3.3. Transmission Electron Microscopy (TEM)

The 5th passage concentrated viral solution was observed under a transmission electron microscope. TEM revealed spherical virus particles measuring approximately 150–220 nm in diameter, each with an envelope and a capsid (Figure 3).

3.4. Indirect Immunofluorescence Assay (IFA)

Immunofluorescence was used to confirm the infection of MDBK cells by the BoAHV1-YBYJ strain. In contrast to the absence of fluorescence in the control group, distinct green fluorescence was observed in the inoculated group (Figure 4), further supporting the successful infection of MDBK cells by BoAHV1-YBYJ.

3.5. Phylogenetic Analysis of Amino Acid Evolution in Isolates

The nucleotide sequence of the BoAHV1-YBYJ gB gene obtained from sequencing was translated into an amino acid sequence. Subsequently, 40 strains of BoAHV1 retrieved from GenBank were selected for constructing a phylogenetic tree (Figure 5). The analysis revealed an amino acid genetic evolutionary tree of the viral proteins, showing two main branches. The BoAHV1-YBYJ isolate (GenBank: OP874961) fell within the secondary branch, showing a close phylogenetic relationship with strains originating from Sichuan (GenBank: MK654723), Egypt (GenBank: MW805275), and the USA (GenBank: MH751901). Conversely, it has a more distant relationship with strains from Xinjiang (GenBank: OQ717037), Beijing (GenBank: JN106443), Hebei (GenBank: MF287966), and Inner Mongolia (GenBank: JN787952), indicating potential cross-border transmission. Furthermore, the amino acid sequence of the DNA virus BoAHV1 is highly conserved, suggesting a low probability of mutation within this virus.

3.6. BoAHV1-YBYJ Glycoprotein Gene Expression in MDBK Cells

After MDBK cells were infected with BoAHV1-YBYJ, GAPDH was chosen as the reference gene to evaluate the relative mRNA expression levels of various glycoproteins at different time points. Specifically, compared with those in the negative control group, the expression of the glycoprotein genes gB (Figure 6a), gE (Figure 6d), and gH (Figure 6e) began at 2 h post-infection, with significant upregulation evident at 6 h. Notably, gB consistently demonstrated the highest expression levels, emphasizing its crucial role throughout the BoAHV1 lifecycle and its potential therapeutic implications. Subsequently, at 4 and 6 h post-infection, the expression of gC (Figure 6b) and gL (Figure 6g), respectively, was detected. gC was significantly upregulated by 12 h, and both gC and gL peaked at 48 h post-infection. Moreover, the expression of gD (Figure 6c) was detected at 12 h post-infection, with relatively subdued levels observed for both gD and gL throughout the entire process. The observed infection dynamics of gC and gD in our study deviate from previous findings [30,31]. Furthermore, gK (Figure 6f) was minimal throughout the infection course. Additionally, the expression levels of glycoprotein genes associated with BoAHV1 in MDBK cells peaked at 48 h post-infection, indicating a subsequent reduction in gene expression. The initial triplicate biological replicate data for this study have been uploaded as Supplementary Material.

4. Discussion

The increasing trade of live cattle and their products, both domestically and internationally, heightens the risk of importing pathogenic microorganisms. In China, IBR is recognized as an infectious disease originating from foreign sources. The initial strain of BoAHV1 was detected in cows imported from New Zealand during the 1980s [14,15,16]. Subsequent serological surveys conducted across various cattle farms nationwide revealed the presence of BoAHV1 in dairy cows, water buffaloes, yellow cattle, and yaks. In recent years, there has been a surge in reports of BoAHV1 infections worldwide, spanning regions such as Iran [32], Brazil [33,34,35], Ireland [36], Turkey [37], Russia [38], and Italy [39]. These infections have led to significant economic losses in husbandry.
IBR extends to sheep and goats [40], while captive Asian elephants exhibit antibodies against this virus [41]. Furthermore, BoAHV1 has been isolated from asymptomatic hosts, including pronghorn antelopes, wildebeests, minks, and ferrets [42], indicating its expanding host range. Given its widespread prevalence in husbandry, it is crucial to prioritize global-scale research on BoAHV1 detection and isolation. This is essential for establishing a strong theoretical framework for mitigating its pervasive impact.
Yanbian Prefecture, comprising eight counties and cities, stands out as a key hub for China’s yellow cattle industry. As one of China’s top five local breeds, Yanbian yellow cattle play a pivotal role in the nation’s husbandry and international trade. The robust disease resistance observed in Yanbian yellow cattle is a result of various factors, such as their adaptation to natural environments, genetic predispositions, effective breeding management practices, and resilience to stressors. Consequently, no previous reports have documented BoAHV1 infection in this breed. This study isolated BoAHV1-positive cases from a cattle farm in Yanji city for the first time and successfully identified a BoAHV1 strain named BoAHV1-YBYJ. Through the analysis of the amino acid evolutionary tree of the isolated strain, we aimed to elucidate its evolutionary characteristics, thereby offering insights into the genetic diversity of BoAHV1. The BoAHV1 genes are classified into immediate early (alpha), early (beta), and late (gamma) categories based on their synthesis within infected cells. The immediate early genes of BoAHV1 (bICP0), early genes (gB, gD), and late genes (gC) have been identified in previous studies [8,43]. However, our study revealed that the expression of BoAHV1-related glycoprotein genes in MDBK cells differed from that in previous reports [30,31], primarily in terms of the expression of the gC and gD genes. Total RNA was extracted from MDBK cells infected with BoAHV1 at various time points, followed by cDNA synthesis and fluorescent quantitative PCR analysis to elucidate the temporal expression dynamics of the virus genes. These findings highlight that during viral infection, gB exhibits the highest expression at the mRNA level, maintaining high expression in the early stages of infection, suggesting its critical role in sustaining infection within host cells. As an essential glycoprotein, gB plays a crucial role in facilitating viral entry, propagation, and spread between infected cells [44]. Additionally, gB acts as a major antigen, inducing the host immune system to produce immune responses, including neutralizing antibodies, which makes it a key target for vaccine development [45]. Future experiments could focus on screening vaccines targeting glycoprotein gB, which may possess increased immunogenicity, effectively eliciting immune responses and providing enhanced protection. Moreover, drugs targeting the gB gene could be investigated to identify compounds capable of disrupting its function, offering promising candidates for antiviral therapeutics [46,47]. The early expression of gC at 4 h post-infection suggested its involvement in initial viral events, indicating a role for gC during the early stages of viral infection. Conversely, gD demonstrates a later expression compared to other genes, indicating its nonessential role in the early phases of infection. Our study findings on gC and gD gene expression dynamics diverge from those of previous reports, underscoring potential variations in viral–host interactions. At 48 h post-infection, the expression of the BoAHV1 glycoprotein peaked. The virus requires a certain duration to replicate and express its genes following cell infection, with its activity gradually waning or stabilizing in subsequent infection stages. This outcome serves as a reminder of the multifactorial regulation governing the virus replication process. It encompasses alterations in the intracellular environment of host cells and the inherent regulatory network of the virus itself. In summary, this study provides valuable insights into the dynamics of BoAHV1 infection, offering pertinent information for the development of vaccines and therapeutic strategies.
Global collaboration and sharing of BoAHV1 isolates are crucial for understanding its transmission and evolution, accelerating vaccine development and treatment strategies, and enhancing global disease control and livestock resilience against IBR. These findings provide valuable insights into BoAHV1 dynamics, paving the way for targeted interventions and vaccine development. Further exploration of the genetic and molecular characteristics of BoAHV1 strains and their interactions with host cells will aid in controlling BoAHV1 infections and safeguarding livestock health.
However, this study has certain limitations. Primarily, the sample source and scope are restricted, with a focus solely on a single yellow cattle farm in Yanbian, China. Consequently, the findings may not fully capture the virus’s spread and impact across various regions and cattle breeds. Additionally, while studies have explored the interaction between BoAHV1 and host cells, our understanding of the pathogenicity and immune evasion mechanisms of this virus in diverse hosts is limited. Therefore, future research endeavors should encompass broader sample collections from different geographic areas and host species, coupled with in-depth molecular biology and immunology analyses, to achieve a comprehensive understanding of BoAHV1 transmission dynamics and pathogenic mechanisms.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/vetsci11080348/s1.

Author Contributions

Conceptualization, X.G. and J.H.; methodology, J.H., H.M. and J.F.; software, J.H. and H.M.; validation, K.Z. (Keyan Zang), H.X., Y.S. and K.Z. (Kunru Zhu); investigation, K.Y.; resources, Y.Z. and M.Y.; data curation, J.H., H.M. and J.F.; writing—original draft preparation, J.H.; writing—review and editing, X.G.; visualization, X.G.; supervision, X.G.; project administration, X.G.; funding acquisition, X.G. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Jilin Province Science and Technology Development Plan Project—“Construction of Comprehensive Prevention and Control and Purification Technology System for Common and New Diseases Caused by Cluster Feeding of Beef Cattle” (No. YDZJ202203CGZH050), funded by the Jilin Provincial Department of Science and Technology; the Animal Husbandry Science and Technology Quality Improvement and Efficiency Enhancement Project—“Demonstration and Promotion of High-Yield and High-Efficiency Breeding Technology for High-Quality Beef Cattle” (No. 202301), funded by the Jilin Provincial Animal Husbandry Management Bureau; and the National Key Research and Development Program Project—“Breeding and Improvement of Beef Cattle Varieties and Research and Development of Advanced Breeding Technology” (No. 2023YFD1300103), funded by the Ministry of Science and Technology of the People’s Republic of China.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Yanbian University (The IACUC Issue No. is YD20231212002 and the date of 12 December 2023).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data that support the findings of this study are available in the Supplementary Material for this article. The partial gB genome sequences of the BoAHV1 isolates (accession number: OP874961) have been submitted to GenBank.

Acknowledgments

The authors would like to thank the members of Gao Laboratory for their critical suggestions.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Khattar, S.K.; van Drunen Littel-van den Harke, S.; Attah-Poku, S.K.; Babiuk, L.A.; Tikoo, S.K. Identification and characterization of a bovine herpesvirus-1 (BHV-1) glycoprotein gL which is required for proper antigenicity, processing, and transport of BHV-1 glycoprotein gH. Virology 1996, 219, 66–76. [Google Scholar] [CrossRef]
  2. Roberts, L.; Wood, D.A.; Hunter, A.R.; Munro, R.; Imray, S.W. Infectious bovine rhinotracheitis. Vet. Rec. 1981, 108, 107. [Google Scholar] [CrossRef]
  3. Durham, P.J. Infectious bovine rhinotracheitis virus and its role in bovine abortion. N. Z. Vet. J. 1974, 22, 175–180. [Google Scholar] [CrossRef] [PubMed]
  4. Bitsch, V. Infectious bovine rhinotracheitis virus infection in bulls, with special reference to preputial infection. Appl. Microbiol. 1973, 26, 337–343. [Google Scholar] [CrossRef]
  5. O’Connor, A.M. Infectious Bovine Keratoconjunctivitis. Vet. Clin. N. Am. Food Anim. Pract. 2021, 37, xi–xii. [Google Scholar] [CrossRef]
  6. Yates, W.D. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can. J. Comp. Med. Rev. Can. Med. Comp. 1982, 46, 225–263. [Google Scholar]
  7. Tikoo, S.K.; Campos, M.; Babiuk, L.A. Bovine herpesvirus 1 (BHV-1): Biology, pathogenesis, and control. Adv. Virus Res. 1995, 45, 191–223. [Google Scholar] [CrossRef] [PubMed]
  8. Tikoo, S.K.; Campos, M.; Popowych, Y.I.; van Drunen Littel-van den Hurk, S.; Babiuk, L.A. Lymphocyte proliferative responses to recombinant bovine herpes virus type 1 (BHV-1) glycoprotein gD (gIV) in immune cattle: Identification of a T cell epitope. Viral Immunol. 1995, 8, 19–25. [Google Scholar] [CrossRef] [PubMed]
  9. Jones, C. Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin. Microbiol. Rev. 2003, 16, 79–95. [Google Scholar] [CrossRef]
  10. Booker, C.W.; Guichon, P.T.; Jim, G.K.; Schunicht, O.C.; Harland, R.J.; Morley, P.S. Seroepidemiology of undifferentiated fever in feedlot calves in western Canada. Can. Vet. J. Rev. Vet. Can. 1999, 40, 40–48. [Google Scholar]
  11. Martin, S.W.; Bateman, K.G.; Shewen, P.E.; Rosendal, S.; Bohac, J.G.; Thorburn, M. A group level analysis of the associations between antibodies to seven putative pathogens and respiratory disease and weight gain in Ontario feedlot calves. Can. J. Vet. Res. Rev. Can. Rech. Vet. 1990, 54, 337–342. [Google Scholar]
  12. Yeşilbağ, K.; Güngör, B. Antibody prevalence against respiratory viruses in sheep and goats in North-Western Turkey. Trop. Anim. Health Prod. 2009, 41, 421–425. [Google Scholar] [CrossRef]
  13. Zhu, L.; Yu, Y.; Jiang, X.; Yuan, W.; Zhu, G. First report of bovine herpesvirus 1 isolation from bull semen samples in China. Acta Virol. 2017, 61, 483–486. [Google Scholar] [CrossRef] [PubMed]
  14. Zhou, T.C.; Ye, Z.M.; Li, S.Q.; Zhong, G.; Gu, Q.J. Infectious bovine rhinotracheitis virus was isolated from cows imported from New Zealand. Chin. Vet. Sci. 1981, 8–11+2. [Google Scholar] [CrossRef]
  15. Feng, Q.M.; Yang, B.Q.; Zhang, R.Z.; Yang, H.Z.; Li, C.L.; Wang, G.X.; Hong, S.W.; Wang, S.Y. The regression test report of infectious bovine rhinotracheitis virus strains isolated from imported New Zealand dairy cows. China Anim. Health Insp. 1982, 20–25. [Google Scholar]
  16. Li, S.G.; Li, Z.G.; Chen, B.W. Report on an outbreak of infectious bovine rhinotracheitis in dairy cows imported from New Zealand. Chin. J. Prev. Vet. 1984, 3, 33–34+2. [Google Scholar]
  17. Metzler, A.E.; Matile, H.; Gassmann, U.; Engels, M.; Wyler, R. European isolates of bovine herpesvirus 1: A comparison of restriction endonuclease sites, polypeptides, and reactivity with monoclonal antibodies. Arch. Virol. 1985, 85, 57–69. [Google Scholar] [CrossRef]
  18. Muylkens, B.; Thiry, J.; Kirten, P.; Schynts, F.; Thiry, E. Bovine herpesvirus 1 infection and infectious bovine rhinotracheitis. Vet. Res. 2007, 38, 181–209. [Google Scholar] [CrossRef] [PubMed]
  19. Favier, P.A.; Marin, M.S.; Pérez, S.E. Role of bovine herpesvirus type 5 (BoHV-5) in diseases of cattle. Recent findings on BoHV-5 association with genital disease. Open Vet. J. 2012, 2, 46–53. [Google Scholar] [CrossRef]
  20. Marawan, M.A.; Deng, M.; Wang, C.; Chen, Y.; Hu, C.; Chen, J.; Chen, X.; Chen, H.; Guo, A. Characterization of BoHV-1 gG-/tk-/gE-Mutant in Differential Protein Expression, Virulence, and Immunity. Vet. Sci. 2021, 8, 253. [Google Scholar] [CrossRef]
  21. Barber, K.A.; Daugherty, H.C.; Ander, S.E.; Jefferson, V.A.; Shack, L.A.; Pechan, T.; Nanduri, B.; Meyer, F. Protein Composition of the Bovine Herpesvirus 1.1 Virion. Vet. Sci. 2017, 4, 11. [Google Scholar] [CrossRef]
  22. Romera, S.A.; Perez, R.; Marandino, A.; LuciaTau, R.; Campos, F.; Roehe, P.M.; Thiry, E.; Maidana, S.S. Whole-genome analysis of natural interspecific recombinant between bovine alphaherpesviruses 1 and 5. Virus Res. 2022, 309, 198656. [Google Scholar] [CrossRef] [PubMed]
  23. van Drunen Littel-van den Hurk, S.; Myers, D.; Doig, P.A.; Karvonen, B.; Habermehl, M.; Babiuk, L.A.; Jelinski, M.; Van Donkersgoed, J.; Schlesinger, K.; Rinehart, C. Identification of a mutant bovine herpesvirus-1 (BHV-1) in post-arrival outbreaks of IBR in feedlot calves and protection with conventional vaccination. Can. J. Vet. Res. Rev. Can. Rech. Vet. 2001, 65, 81–88. [Google Scholar]
  24. Wu, C.T.; Li, Y.M.; Tang, S.G. Prokaryotic expression of gB gene of bovine herpesvirus-1and establishment of an indirect ELISA based on the recombinant fusion protein. Chin. Vet. Sci. 2010, 40, 1259–1264. [Google Scholar] [CrossRef]
  25. Chowdhury, S.I.; Wei, H.; Weiss, M.; Pannhorst, K.; Paulsen, D.B. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge. Vaccine 2014, 32, 4909–4915. [Google Scholar] [CrossRef]
  26. Wang, H.J.; Wang, S.H.; Chang, L.L.; Chen, H.J. Development of taqman probe real-time quantitative pcr to detect gb gene of bovine infectious rhinotracheitis virus. Chin. J. Anim. Infect. Dis. 2017, 25, 64–67. [Google Scholar]
  27. Xu, N.; Yang, F.; Lei, Y.; Li, P.A.; Guan, T.Y. Establishment of duplex real-time PCR assay for detection of infectious bovine rhinotracheitis virus gB and gE genes. Chin. J. Prev. Vet. Med. 2017, 39, 556–559. [Google Scholar]
  28. Granátová, M.; Psikal, I. [Cell-mediated immunity in calves immunized against or infected with the bovine rhinotracheitis virus]. Vet. Med. 1989, 34, 385–394. [Google Scholar]
  29. Hou, L.N.; Wu, Z.W.; Zhang, K.; Gao, H.J. Current Status, Issues, and Countermeasures of Conservation Work for the Yellow Cattle in Yanbian Region. J. Jilin Agric. Univ. 2023, 45, 396–401. [Google Scholar] [CrossRef]
  30. Ludwig, G.V.; Letchworth, G.J., 3rd. Temporal control of bovine herpesvirus 1 glycoprotein synthesis. J. Virol. 1987, 61, 3292–3294. [Google Scholar] [CrossRef]
  31. Baranowski, E.; Keil, G.; Lyaku, J.; Rijsewijk, F.A.; van Oirschot, J.T.; Pastoret, P.P.; Thiry, E. Structural and functional analysis of bovine herpesvirus 1 minor glycoproteins. Vet. Microbiol. 1996, 53, 91–101. [Google Scholar] [CrossRef] [PubMed]
  32. Karimi, O.; Bitaraf Sani, M.; Bakhshesh, M.; Zareh Harofteh, J.; Poormirzayee-Tafti, H. Prevalence of bovine herpesvirus 1 antibodies and risk factors in dairy cattle of Iran’s central desert. Trop. Anim. Health Prod. 2022, 55, 23. [Google Scholar] [CrossRef] [PubMed]
  33. Campos, F.S.; Franco, A.C.; Hübner, S.O.; Oliveira, M.T.; Silva, A.D.; Esteves, P.A.; Roehe, P.M.; Rijsewijk, F.A. High prevalence of co-infections with bovine herpesvirus 1 and 5 found in cattle in southern Brazil. Vet. Microbiol. 2009, 139, 67–73. [Google Scholar] [CrossRef] [PubMed]
  34. Fernandes, L.G.; Denwood, M.J.; de Sousa Américo Batista Santos, C.; Alves, C.J.; Pituco, E.M.; de Campos Nogueira Romaldini, A.H.; De Stefano, E.; Nielsen, S.S.; de Azevedo, S.S. Bayesian estimation of herd-level prevalence and risk factors associated with BoHV-1 infection in cattle herds in the State of Paraíba, Brazil. Prev. Vet. Med. 2019, 169, 104705. [Google Scholar] [CrossRef] [PubMed]
  35. Oliveira, M.T.; Campos, F.S.; Dias, M.M.; Velho, F.A.; Freneau, G.E.; Brito, W.M.; Rijsewijk, F.A.; Franco, A.C.; Roehe, P.M. Detection of bovine herpesvirus 1 and 5 in semen from Brazilian bulls. Theriogenology 2011, 75, 1139–1145. [Google Scholar] [CrossRef] [PubMed]
  36. Barrett, D.; Lane, E.; Lozano, J.M.; O’Keeffe, K.; Byrne, A.W. Bovine Herpes Virus Type 1 (BoHV-1) seroprevalence, risk factor and Bovine Viral Diarrhoea (BVD) co-infection analysis from Ireland. Sci. Rep. 2024, 14, 867. [Google Scholar] [CrossRef] [PubMed]
  37. Dagalp, S.B.; Farzani, T.A.; Dogan, F.; Alkan, F.; Ozkul, A. Molecular and antigenic characterization of bovine herpesvirus type 1 (BoHV-1) strains from cattle with diverse clinical cases in Turkey. Trop. Anim. Health Prod. 2020, 52, 555–564. [Google Scholar] [CrossRef] [PubMed]
  38. Pchelnikov, A.V.; Yatsenyuk, S.P.; Krasnikova, M.S. Circulation of bovine herpesvirus (Herpesviridae: Varicellovirus) and bovine viral diarrhea virus (Flaviviridae: Pestivirus) among wild artiodactyls of the Moscow region. Vopr. Virusol. 2023, 68, 142–151. [Google Scholar] [CrossRef]
  39. Esposito, C.; Fiorito, F.; Miletti, G.; Serra, F.; Balestrieri, A.; Cioffi, B.; Cerracchio, C.; Galiero, G.; De Carlo, E.; Amoroso, M.G.; et al. Involvement of herpesviruses in cases of abortion among water buffaloes in southern Italy. Vet. Res. Commun. 2022, 46, 719–729. [Google Scholar] [CrossRef]
  40. Whetstone, C.A.; Evermann, J.F. Characterization of bovine herpesviruses isolated from six sheep and four goats by restriction endonuclease analysis and radioimmunoprecipitation. Am. J. Vet. Res. 1988, 49, 781–785. [Google Scholar]
  41. Menvík, J.; Pospísil, Z.; Suchánková, A.; Cepicá, A.; Rozkosný, V.; Machatková, M. Activation of latent infectious bovine rhinotracheitis after experimental infection with parainfluenza 3 virus in young calves. Zentralblatt Fur Vet. Reihe B J. Vet. Med. Ser. B 1976, 23, 854–864. [Google Scholar] [CrossRef]
  42. Porter, D.D.; Larsen, A.E.; Cox, N.A. Isolation of infectious bovine rhinotracheitis virus from Mustelidae. J. Clin. Microbiol. 1975, 1, 112–113. [Google Scholar] [CrossRef] [PubMed]
  43. Jones, C.; Chowdhury, S. A review of the biology of bovine herpesvirus type 1 (BHV-1), its role as a cofactor in the bovine respiratory disease complex and development of improved vaccines. Anim. Health Res. Rev. 2007, 8, 187–205. [Google Scholar] [CrossRef] [PubMed]
  44. Keil, G.M.; Klopfleisch, C.; Giesow, K.; Veits, J. Protein display by bovine herpesvirus type 1 glycoprotein B. Vet. Microbiol. 2010, 143, 29–36. [Google Scholar] [CrossRef] [PubMed]
  45. Okazaki, K.; Fujii, S.; Takada, A.; Kida, H. The amino-terminal residue of glycoprotein B is critical for neutralization of bovine herpesvirus 1. Virus Res. 2006, 115, 105–111. [Google Scholar] [CrossRef]
  46. Li, Y.; van Drunen Littel-van den Hurk, S.; Liang, X.; Babiuk, L.A. The cytoplasmic domain of bovine herpesvirus 1 glycoprotein B is important for maintaining conformation and the high-affinity binding site of gB. Virology 1996, 222, 262–268. [Google Scholar] [CrossRef] [PubMed]
  47. Li, Y.; van Drunen Littel-van den Hurk, S.; Liang, X.; Babiuk, L.A. Functional analysis of the transmembrane anchor region of bovine herpesvirus 1 glycoprotein gB. Virology 1997, 228, 39–54. [Google Scholar] [CrossRef]
Figure 1. PCR detection results for pending samples. Lane M, DL 2000 Marker; lane 1, negative control; lane 2, positive sample.
Figure 1. PCR detection results for pending samples. Lane M, DL 2000 Marker; lane 1, negative control; lane 2, positive sample.
Vetsci 11 00348 g001
Figure 2. BoAHV1-YBYJ isolation from Yanbian yellow cattle. MDBK cells were infected by the 5th passage of the virus samples. CPE could be visualized 40 h post-infection (100× magnification). (a) Cells infected with the 5th passage of the virus sample. (b) Mock infection control. (c) BoAHV1-YBYJ virus growth curve.
Figure 2. BoAHV1-YBYJ isolation from Yanbian yellow cattle. MDBK cells were infected by the 5th passage of the virus samples. CPE could be visualized 40 h post-infection (100× magnification). (a) Cells infected with the 5th passage of the virus sample. (b) Mock infection control. (c) BoAHV1-YBYJ virus growth curve.
Vetsci 11 00348 g002aVetsci 11 00348 g002b
Figure 3. TEM was used to observe the viral morphology of BoAHV1 (30,000× magnification). Viral particles are highlighted with red arrows.
Figure 3. TEM was used to observe the viral morphology of BoAHV1 (30,000× magnification). Viral particles are highlighted with red arrows.
Vetsci 11 00348 g003
Figure 4. MDBK cells infected with the BoAHV1-YBYJ strain were detected using IFA. Inoculation group: distinct green fluorescence (100× magnification). (a) Cells infected with the BoAHV1-YBYJ strain; (b) mock infection control.
Figure 4. MDBK cells infected with the BoAHV1-YBYJ strain were detected using IFA. Inoculation group: distinct green fluorescence (100× magnification). (a) Cells infected with the BoAHV1-YBYJ strain; (b) mock infection control.
Vetsci 11 00348 g004
Figure 5. A phylogenetic tree based on the partial gB sequences of BoAHV1 was constructed via the neighbor-joining method. Amino acid sequences were analyzed using MegAlign software 7.1.0 (44) with a bootstrap test of 1000 replicates. The red font represents the currently isolated BoAHV1 strain (YBYJ).
Figure 5. A phylogenetic tree based on the partial gB sequences of BoAHV1 was constructed via the neighbor-joining method. Amino acid sequences were analyzed using MegAlign software 7.1.0 (44) with a bootstrap test of 1000 replicates. The red font represents the currently isolated BoAHV1 strain (YBYJ).
Vetsci 11 00348 g005
Figure 6. The expression patterns of BoAHV1-associated glycoprotein genes in MDBK cells over time compared with those in the mock group. (a) Relative gB mRNA expression; (b) relative gC mRNA expression; (c) relative gD mRNA expression; (d) relative gE mRNA expression; (e) relative gH mRNA expression; (f) relative gK mRNA expression; (g) relative gL mRNA expression. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.
Figure 6. The expression patterns of BoAHV1-associated glycoprotein genes in MDBK cells over time compared with those in the mock group. (a) Relative gB mRNA expression; (b) relative gC mRNA expression; (c) relative gD mRNA expression; (d) relative gE mRNA expression; (e) relative gH mRNA expression; (f) relative gK mRNA expression; (g) relative gL mRNA expression. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.
Vetsci 11 00348 g006aVetsci 11 00348 g006b
Table 1. The primers used in this study.
Table 1. The primers used in this study.
PrimersPrimer Sequences (5′-3′)Product Size (bp)
BoAHV1-gBBoAHV1-gB-F:
GCCGTGAAGCGGAAGTT
BoAHV1-gB-R:
CCTGGTGGACAAGAAGTGG
567
BoAHV1-qgBBoAHV1-qgB-F:
GGCTCGCCAACTTCTTTCA
BoAHV1-qgB-R:
AACGGGTTCGCAATAAACG
124
BoAHV1-qgCBoAHV1-qgC-F:
CCCGTGCTGCTGTTCGTAG
BoAHV1-qgC-R:
GACTTGGTGCCCATGTCGC
176
BoAHV1-qgDBoAHV1-qgD-F:
GGATTACGAGCAAAAGAAGGTT
BoAHV1-qgD-R:
CAAAATACGGCGGAACGAC
125
BoAHV1-qgEBoAHV1-qgE-F:
GACATCCTCAACCCCTTCG
BoAHV1-qgE-R:
CTGTCGTCATCCGCAAAAG
125
BoAHV1-qgHBoAHV1-qgH-F:
CCTACTGCGGCAGCGTGTT
BoAHV1-qgH-R:
GAGGCGAGGGTTGAAGACG
137
BoAHV1-qgKBoAHV1-qgK-F:
CGCTTGCTGTCAACTTCCG
BoAHV1-qgK-R:
AACCCACGCCCAGATTTTC
188
BoAHV1-qgLBoAHV1-qgL-F:
GGCAACTTATTGCTCGCAGAC
BoAHV1-qgL-R:
GGCAAGCACCCGCCTTATA
189
GAPDHGAPDH-F:
GACCTGCCGCCTGGAGAA
GAPDH-R:
GAAGAGTGAGTGTCGCTGTTGA
144
Table 2. The sequences used in this study.
Table 2. The sequences used in this study.
Sequence NameGenBank IDLocation
BoAHV1OP874961Yanji
BoAHV1AY330349Brazil
BoAHV1AY745875Brazil
BoAHV1AY758382Brazil
BoAHV1DQ006850Brasil
BoAHV1DQ006853Brasil
BoAHV1DQ006854Brasil
BoAHV1DQ006856Brasil
BoAHV1JN787952Inner Mongolia
BoAHV1KF584167Israel
BoAHV1KF584168Israel
BoAHV1KF734609India
BoAHV1KY348790Xinjiang
BoAHV1MG407776USA
BoAHV1MH751901USA
BoAHV1MK654723Sichuan
BoAHV1MW805275Egypt
BoAHV1JN106443Beijing
BoAHV1JN106444Beijing
BoAHV1JN106445Beijing
BoAHV1JN106446Beijing
BoAHV1JN106447Beijing
BoAHV1JN106448Beijing
BoAHV1MF287966Hebei
BoAHV1.1AF078724Sweden
BoAHV1.1KJ652513USA
BoAHV1.1KJ652514USA
BoAHV1.1KJ652515USA
BoAHV1.1KJ652516USA
BoAHV1.1KJ652519Egypt
BoAHV1.2AF078725Sweden
BoAHV1.2OQ126881Sichuan
BoAHV1.2OQ717034Sichuan
BoAHV1.2OQ717037Xinjiang
BoAHV5AF078726Switzerland
BoAHV5KM252881Brazil
BoAHV5KM252893Brazil
BoAHV5OK651227Russia
BoAHV5OQ608621India
BoAHV5PP336333Turkey
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Hao, J.; Fu, J.; Yu, K.; Gao, X.; Zang, K.; Ma, H.; Xue, H.; Song, Y.; Zhu, K.; Yang, M.; et al. Isolation of the Initial Bovine Alphaherpesvirus 1 Isolate from Yanbian, China. Vet. Sci. 2024, 11, 348. https://doi.org/10.3390/vetsci11080348

AMA Style

Hao J, Fu J, Yu K, Gao X, Zang K, Ma H, Xue H, Song Y, Zhu K, Yang M, et al. Isolation of the Initial Bovine Alphaherpesvirus 1 Isolate from Yanbian, China. Veterinary Sciences. 2024; 11(8):348. https://doi.org/10.3390/vetsci11080348

Chicago/Turabian Style

Hao, Jingrui, Jingfeng Fu, Kai Yu, Xu Gao, Keyan Zang, Haoyuan Ma, Haowen Xue, Yanhao Song, Kunru Zhu, Meng Yang, and et al. 2024. "Isolation of the Initial Bovine Alphaherpesvirus 1 Isolate from Yanbian, China" Veterinary Sciences 11, no. 8: 348. https://doi.org/10.3390/vetsci11080348

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop